These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36264968)

  • 1. Toward Project Optimus for Oncology Precision Medicine: Multi-Dimensional Dose Optimization Enabled by Quantitative Clinical Pharmacology.
    Venkatakrishnan K; van der Graaf PH
    Clin Pharmacol Ther; 2022 Nov; 112(5):927-932. PubMed ID: 36264968
    [No Abstract]   [Full Text] [Related]  

  • 2. Optimizing Tomorrow's Drug Development with Project Optimus: Precision Dosing IS Precision Oncology.
    Subbiah V
    Ann Oncol; 2024 Oct; 35(10):836-839. PubMed ID: 39233313
    [No Abstract]   [Full Text] [Related]  

  • 3. Delivering precision oncology to patients with cancer.
    Mateo J; Steuten L; Aftimos P; André F; Davies M; Garralda E; Geissler J; Husereau D; Martinez-Lopez I; Normanno N; Reis-Filho JS; Stefani S; Thomas DM; Westphalen CB; Voest E
    Nat Med; 2022 Apr; 28(4):658-665. PubMed ID: 35440717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivering on the promise of precision cancer medicine.
    Berger MF; Van Allen EM
    Genome Med; 2016 Oct; 8(1):110. PubMed ID: 27782852
    [No Abstract]   [Full Text] [Related]  

  • 5. Personalized Medicine: Genomics Trials in Oncology.
    Hayes DF; Schott AF
    Trans Am Clin Climatol Assoc; 2015; 126():133-43. PubMed ID: 26330667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
    Rodriguez H; Pennington SR
    Cell; 2018 Apr; 173(3):535-539. PubMed ID: 29677503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Age of Omics-Driven Precision Medicine.
    McColl ER; Asthana R; Paine MF; Piquette-Miller M
    Clin Pharmacol Ther; 2019 Sep; 106(3):477-481. PubMed ID: 31407329
    [No Abstract]   [Full Text] [Related]  

  • 8. Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
    Saulsberry L; Olopade OI
    Cancer Cell; 2021 Jun; 39(6):730-733. PubMed ID: 34019805
    [No Abstract]   [Full Text] [Related]  

  • 9. Enabling Precision Oncology Through Precision Diagnostics.
    Brown NA; Elenitoba-Johnson KSJ
    Annu Rev Pathol; 2020 Jan; 15():97-121. PubMed ID: 31977297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Medicine Takes the Stage, Again!
    Tempero M
    J Natl Compr Canc Netw; 2018 Jul; 16(7):795. PubMed ID: 30006420
    [No Abstract]   [Full Text] [Related]  

  • 11. The Role of Clinical Pharmacology in Oncology Dose Selection: Advances and Opportunities in Personalized Medicine.
    Shord SS
    J Clin Pharmacol; 2017 Oct; 57 Suppl 10():S99-S104. PubMed ID: 28921640
    [No Abstract]   [Full Text] [Related]  

  • 12. Harnessing cancer genomes for precision oncology.
    Chanock SJ
    Nat Genet; 2024 Sep; 56(9):1768-1769. PubMed ID: 39164499
    [No Abstract]   [Full Text] [Related]  

  • 13. Embracing Project Optimus: Can we Leverage Evolutionary Theory to Optimize Dosing in Oncology?
    Qi T; Dunlap T; Cao Y
    Pharm Res; 2022 Dec; 39(12):3259-3265. PubMed ID: 36056271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Precision medicine in oncology: what contribution to clinical practice?].
    Cardone C; De Stefano A
    Recenti Prog Med; 2023 Jun; 114(6):355-358. PubMed ID: 37229682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. My mission is possible: discussing ethical concerns about genomics and precision medicine.
    Giusti R
    Recenti Prog Med; 2021 Jun; 112(6):416-418. PubMed ID: 34128933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The era of precision oncogenomics.
    Carpten JC; Mardis ER
    Cold Spring Harb Mol Case Stud; 2018 Apr; 4(2):. PubMed ID: 29610397
    [No Abstract]   [Full Text] [Related]  

  • 17. A Quantitative Paradigm for Decision-Making in Precision Oncology.
    Engelhardt D; Michor F
    Trends Cancer; 2021 Apr; 7(4):293-300. PubMed ID: 33637444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relevance of Hereditary Cancer Risks to Precision Oncology: What Should Providers Consider When Conducting Tumor Genomic Profiling?
    Jain R; Savage MJ; Forman AD; Mukherji R; Hall MJ
    J Natl Compr Canc Netw; 2016 Jun; 14(6):795-806. PubMed ID: 27283171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
    Nadauld LD; Ford JM; Pritchard D; Brown T
    Health Aff (Millwood); 2018 May; 37(5):751-756. PubMed ID: 29733728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal Genomic Testing: The next step in oncological decision-making or a dead end street?
    Holch JW; Metzeler KH; Jung A; Riedmann K; Jost PJ; Weichert W; Kirchner T; Heinemann V; Westphalen CB
    Eur J Cancer; 2017 Sep; 82():72-79. PubMed ID: 28648701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.